Software Products & Services was Schrodinger’s largest product and service line in fiscal 2025, bringing in $199.50M of $255.87M (78%).
| Product and Service | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|
| Software Products & Services | $135.58M | $159.12M | $180.37M | $199.50M | |||
| On-Premise Software | — | — | — | — | |||
| On Premise Software | — | — | — | — | |||
| Drug Discovery | $45.38M | $57.54M | $27.17M | $56.37M | |||
| Software Maintenance | — | — | — | — | |||
| Hosted Software | — | — | — | — | |||
| Professional Services | — | — | — | — | |||
| Software Contribution | — | — | — | — | |||
| Total | $180.96M | $216.67M | $207.54M | $255.87M |
Schrodinger brought in $255.87M from its two product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 23.3% from $207.54M in fiscal 2024. Software Products & Services was the largest at $199.50M (78.0%), ahead of Drug Discovery at $56.37M (22.0%).
Compared with fiscal 2024, Drug Discovery grew 107.4% to $56.37M and Software Products & Services grew 10.6% to $199.50M. From fiscal 2022 to 2025, combined revenue from these lines grew from $180.96M to $255.87M, a compound annual growth rate of 12.2%. Software Products & Services' share of the total rose from 74.9% to 78.0%.
United States was Schrodinger’s largest region in fiscal 2025, bringing in $152.96M of $255.87M (60%).
| Geography | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|
| United States | $123.56M | $161.96M | $114.87M | $152.96M | |||
| Emea | $34.45M | $29.14M | $65.65M | $75.16M | |||
| Apac | $21.68M | $24.57M | $25.80M | $26.18M | |||
| Europe | — | — | — | — | |||
| Japan | — | — | — | — | |||
| Rest Of World | $1.27M | $1.00M | $1.22M | $1.56M | |||
| Total | $180.96M | $216.67M | $207.54M | $255.87M |
Schrodinger brought in $255.87M from its four regions in fiscal 2025, the year ended December 31, 2025. That was up 23.3% from $207.54M in fiscal 2024. United States was the largest at $152.96M (59.8%), ahead of Emea at $75.16M (29.4%) and Apac at $26.18M (10.2%). The remaining region, Rest Of World, brought in $1.56M.
Compared with fiscal 2024, United States grew fastest, up 33.2% to $152.96M. Every region above 2% of revenue grew. From fiscal 2022 to 2025, combined revenue from these regions grew from $180.96M to $255.87M, a compound annual growth rate of 12.2%. United States' share of the total fell from 68.3% to 59.8%.
Software was Schrodinger’s largest segment in fiscal 2025, bringing in $199.50M of $255.87M (78%).
| Segment | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|
| Software | $135.58M | $159.12M | $180.37M | $199.50M | |||
| Drug Discovery | $45.38M | $57.54M | $27.17M | $56.37M | |||
| Total | $180.96M | $216.67M | $207.54M | $255.87M |
Schrodinger brought in $255.87M from its two segments in fiscal 2025, the year ended December 31, 2025. That was up 23.3% from $207.54M in fiscal 2024. Software was the largest at $199.50M (78.0%), ahead of Drug Discovery at $56.37M (22.0%).
Compared with fiscal 2024, Drug Discovery grew 107.4% to $56.37M and Software grew 10.6% to $199.50M. From fiscal 2022 to 2025, combined revenue from these segments grew from $180.96M to $255.87M, a compound annual growth rate of 12.2%. Software's share of the total rose from 74.9% to 78.0%.
Schrodinger (SDGR) reports its revenue by product and service, by geography and by segment. In fiscal 2025, Software Products & Services was its largest product and service line, bringing in $199.50M (78.0% of the total), followed by Drug Discovery at $56.37M (22.0%).
Software Products & Services was Schrodinger's largest product and service line in fiscal 2025, bringing in $199.50M, or 78.0% of the $255.87M total across its two product and service lines.
United States was Schrodinger's largest region in fiscal 2025, bringing in $152.96M, or 59.8% of the $255.87M total across its four regions.
Software was Schrodinger's largest segment in fiscal 2025, bringing in $199.50M, or 78.0% of the $255.87M total across its two segments.
Drug Discovery grew faster than Software Products & Services in fiscal 2025, up 107.4% from $27.17M to $56.37M. Software Products & Services grew 10.6% to $199.50M.
Every figure comes from Schrodinger's annual financial filings, as reported. Each line keeps the name Schrodinger gives it, and years follow its fiscal calendar.
Schrodinger's revenue by product and service goes back to fiscal 2019, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.